As of 3:59pm ET
| +0.59 / +1.26%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 62.50, with a high estimate of 69.00 and a low estimate of 56.00. The median estimate represents a +31.86% increase from the last price of 47.40.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.